Highland Capital Management, LLC Abb Vie Inc. Transaction History

Highland Capital Management, LLC

$1.73 Billion
Q3 2024

A detailed history of Highland Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Highland Capital Management, LLC holds 46,731 shares of ABBV stock, worth $8.27 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

46,731

Previous 23,168 101.7%

Holding current value

$8.27 Million

Previous $3.97 Million 132.27%

% of portfolio

0.53%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $3.86 Million - $4.7 Million	23,563 Added 101.7%	46,731 $9.23 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $509,413 - $594,881	-3,291 Reduced 12.44%	23,168 $3.97 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $7,351 - $8,376	-46 Reduced 0.17%	26,459 $4.82 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $7,292 - $8,213	-53 Reduced 0.2%	26,505 $4.11 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.01 Million - $1.17 Million	-7,549 Reduced 22.13%	26,558 $3.96 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $528,582 - $657,786	-3,989 Reduced 10.47%	34,107 $4.6 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $1.6 Million - $1.84 Million	11,038 Added 40.79%	38,096 $6.07 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $107,190 - $128,549	-775 Reduced 2.78%	27,058 $4.37 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $52,610 - $60,340	392 Added 1.43%	27,833 $3.74 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $34,405 - $43,740	250 Added 0.92%	27,441 $4.2 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $20,984 - $26,036	-159 Reduced 0.58%	27,191 $4.41 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $32,014 - $40,507	-298 Reduced 1.08%	27,350 $3.7 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $4.97 Million - $5.64 Million	-46,669 Reduced 62.8%	27,648 $2.98 Million
Q2 2021 Jul 30, 2021	SELL	$105.21 - $117.21 $337,303 - $375,775	-3,206 Reduced 4.14%	74,317 $8.37 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $4.75 Million - $5.23 Million	46,443 Added 149.43%	77,523 $8.39 Million
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $215,713 - $291,235	-2,680 Reduced 7.94%	31,080 $3.33 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $515 - $604	-6 Reduced 0.02%	33,760 $2.96 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $589,161 - $788,385	8,030 Added 31.2%	33,766 $3.32 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $270,835 - $410,620	-4,199 Reduced 14.03%	25,736 $1.96 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $2.16 Million - $2.7 Million	29,935 New	29,935 $2.65 Million
Q3 2019 Nov 20, 2019	SELL	$62.98 - $75.72 $1.37 Million - $1.65 Million	-21,738 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $19,315 - $24,690	-294 Reduced 1.33%	21,738 $1.58 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $99,433 - $117,028	-1,289 Reduced 5.53%	22,032 $1.78 Million
Q4 2018 Jan 16, 2019	SELL	$77.85 - $96.01 $2,257 - $2,784	-29 Reduced 0.12%	23,321 $2.15 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $138,432 - $153,893	1,557 Added 7.14%	23,350 $2.21 Million
Q2 2018 Jul 18, 2018	SELL	$89.78 - $106.23 $152,626 - $180,591	-1,700 Reduced 7.24%	21,793 $2.02 Million
Q1 2018 Apr 16, 2018	BUY	$92.01 - $123.21 $248,519 - $332,790	2,701 Added 12.99%	23,493 $2.22 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $374,987 - $411,205	-4,187 Reduced 16.76%	20,792 $2.01 Million
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $1.74 Million - $2.23 Million	24,979	24,979 $2.22 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Account

Highland Capital Management, LLC Abb Vie Inc. Transaction History